CHD Team

The U.S. Food and Drug Administration (FDA) last week granted Novavax Emergency Use Authorization (EUA) for its COVID-19 vaccine, for adults age 18 and up.

… The media’s obliging sales pitch is that the Novavax injection is a “game changer” in comparison to the mRNA and adenovirus-vectored gene therapy shots, and should be “reassuring to those who are hesitant.”

In fact, according to the CDC’s advisors, the unvaccinated represent the “primary target population for Novavax.”